IRB-reviewed studies
Every study at VMRC runs under Institutional Review Board oversight and informed consent.
Patient Recruitment
Find a clinical study designed for you.
Explore available studies in Miami and learn how to take part.
Your information is protected and confidential.
Current studies
1 clinical study in Miami
Can't find a study for you?
Join our volunteer registry and we'll reach out when the right opportunity opens for you.
Track record
30 clinical studies conducted at VMRC
Pharmaceutical sponsors, biotech companies and academic research networks have run their protocols here — from Phase I to Phase III, in adults, adolescents and young children. Each registered study links to its public record.
- Sponsors
- 17
- Pediatric studies
- 10
- Phases conducted
- Phases 1 to 3
Sponsors with studies at VMRC
- AbbVie (6 studies)
- Ardelyx (4 studies)
- Areteia Therapeutics (2 studies)
- AstraZeneca (2 studies)
- Duke University (NIH RECOVER) (2 studies)
- Iterum Therapeutics (2 studies)
- Landos Biopharma (2 studies)
- Atea Pharmaceuticals (1 study)
- Chiesi (1 study)
- Cue Health (1 study)
- Dermtreat (1 study)
- Guardant Health (1 study)
- Ironwood Pharmaceuticals (1 study)
- Sanofi (1 study)
- Shionogi (1 study)
- Sun Pharma (1 study)
- Uniquity One (1 study)
Study register
30 studies shown
- Start: 2026NCT07382167 — ClinicalTrials.gov (opens in a new tab)
Chronic idiopathic constipation
- Start: 2026NCT07556159 — ClinicalTrials.gov (opens in a new tab)
Asthma
- Start: 2025NCT07133308 — ClinicalTrials.gov (opens in a new tab)
Severe alopecia areata, adolescents
- Start: 2024NCT06553547 — ClinicalTrials.gov (opens in a new tab)
IBS with constipation, ages 6–11
- Start: 2024NCT06404047 — ClinicalTrials.gov (opens in a new tab)
Long COVID rehabilitation
- Start: 2024NCT06496620 — ClinicalTrials.gov (opens in a new tab)
COPD
- Start: 2023NCT05905926 — ClinicalTrials.gov (opens in a new tab)
IBS with constipation, pediatric long-term safety
- Start: 2023NCT05760313 — ClinicalTrials.gov (opens in a new tab)
Functional constipation in infants
- Start: 2023NCT05748600 — ClinicalTrials.gov (opens in a new tab)
Eosinophilic asthma
- Start: 2023NCT05813288 — ClinicalTrials.gov (opens in a new tab)
Severe eosinophilic asthma
- Start: 2023NCT05740007 — ClinicalTrials.gov (opens in a new tab)
Interstitial cystitis / bladder pain syndrome
- Start: 2023Device study
Strep A rapid diagnostic test
- Start: 2023NCT05897541 — ClinicalTrials.gov (opens in a new tab)
Prevention of symptomatic COVID-19
- Start: 2023NCT05595369 — ClinicalTrials.gov (opens in a new tab)
Long COVID
- Start: 2022NCT05117840 — ClinicalTrials.gov (opens in a new tab)
Lung cancer screening
- Start: 2022NCT04320342 — ClinicalTrials.gov (opens in a new tab)
COPD with exacerbations
- Start: 2022NCT05629962 — ClinicalTrials.gov (opens in a new tab)
COVID-19 in high-risk outpatients
- Start: 2022NCT05584657 — ClinicalTrials.gov (opens in a new tab)
Uncomplicated urinary tract infection
- Start: 2022NCT05652205 — ClinicalTrials.gov (opens in a new tab)
Functional constipation, ages 2–5
- Start: 2022NCT05643534 — ClinicalTrials.gov (opens in a new tab)
IBS with constipation, adolescents
- Start: 2021NCT04880876 — ClinicalTrials.gov (opens in a new tab)
Irritable bowel syndrome with diarrhea, pediatric long-term
- Start: 2021NCT04862741 — ClinicalTrials.gov (opens in a new tab)
Active ulcerative colitis
- Start: 2021NCT03870334 — ClinicalTrials.gov (opens in a new tab)
Moderate to severe Crohn's disease
- Start: 2019NCT04026113 — ClinicalTrials.gov (opens in a new tab)
Functional constipation and IBS-C, pediatric
- Start: 2019NCT04166058 — ClinicalTrials.gov (opens in a new tab)
Functional constipation and IBS-C, pediatric long-term safety
- Start: 2018NCT03592342 — ClinicalTrials.gov (opens in a new tab)
Oral lichen planus
- Start: 2018NCT03354598 — ClinicalTrials.gov (opens in a new tab)
Uncomplicated urinary tract infection
- Start: 2018NCT03616821 — ClinicalTrials.gov (opens in a new tab)
Moderate to severe ulcerative colitis
- Start: 2018NCT03759288 — ClinicalTrials.gov (opens in a new tab)
Moderate to severe Crohn's disease
- Start: 2017NCT03339128 — ClinicalTrials.gov (opens in a new tab)
Irritable bowel syndrome with diarrhea, pediatric
Phase, ages and start year come from each study's public record on ClinicalTrials.gov. Status refers to VMRC's participation as a site.
How we support you throughout the study.
How participation works
A simple, supported process.
Online · about 5 minutes
Illustrative images.
Before you decide
What to know
before taking part.
What is a clinical study?
A research study that evaluates a treatment under a written protocol. Every protocol is reviewed and approved by an independent ethics board (IRB) before a single participant is enrolled, and the study team follows it visit by visit.
Does taking part cost me anything?
Study visits and study procedures are provided at no cost to you, and no insurance is required to participate. What each study covers, including the investigational medication, is written in its consent form, which you review before agreeing to anything.
Who oversees my safety?
A licensed physician serves as principal investigator and is responsible for your care throughout the study. An independent IRB reviews the protocol before it starts and continues to oversee it, and every visit is documented under the supervision of the study's principal investigator.
Will I be paid?
Studies that offer compensation pay for your time and travel, not for taking a medication. The exact amount and schedule are written in the consent form for that specific study, and you review it before agreeing to anything.
Can I leave once I have started?
Yes, at any time and for any reason. Participation is voluntary from the first visit to the last; withdrawing does not affect your regular medical care and you do not have to explain your decision.
What happens to my personal information?
Your records are kept confidential under Florida law and the study's consent form. Data shared with a study sponsor is coded, and your name is not used in any published result.
Still deciding?Talk it through with our team
Why people trust us
Three promises behind every study.
Your data stays yours
Your information is protected, confidential, and handled under our Notice of Privacy Practices.
Bilingual, human team
English or Spanish, from the first call to your last visit — with a team that knows you by name.
Not sure where to start
Need help
finding a study?
Our AI study assistant can guide you in English or Spanish.
- English or Spanish
- No commitment